Rendering

Component: (Network and Table)
Network
143 - Disclosure - Accrued Expenses and Other Liabilities - Schedule of Accrued Expenses and Other Liabilities (Detail)
(http://www.catalystpharma.com/taxonomy/role/DisclosureAccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilities)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001369568 (http://www.sec.gov/CIK)
Payables And Accruals [Abstract]Period [Axis]
2013-12-31
2012-12-31
Payables And Accruals [Abstract]
 
 
Accrued pre-clinical and clinical trial expenses
1,083,749  
197,572  
Accrued professional fees
117,240  
51,050  
Accrued compensation and benefits
14,539  
5,949  
Accrued license fees
65,000  
15,000  
Deferred rent
2,746  
765  
Other
5,546  
10,666  
Current accrued expenses and other liabilities
1,288,820  
 
281,002  
 
Deferred rent-non-current
19,131  
21,878  
Non-current accrued expenses and other liabilities
19,131  
 
21,878  
 
Total accrued expenses and other liabilities
1,307,951  
 
302,880